Here's Why Senseonics Jumped Higher Today
Shares of Senseonics (NYSEMKT: SENS) are up 13% at 12:52 p.m. EST after the company presented data on its Eversense continuous glucose monitoring system at the Advanced Technologies and Treatments for Diabetes conference in Madrid, Spain, last week.
Investors are also likely reacting to the Soros Fund -- run by famed investor George Soros -- disclosing a 5.1% stake in the company.
Senseonics looked at real-world data from almost 600 Eversense users, and found that all age groups met the recommendation of wearing the device at least 70% of the time. The time that patients wore the device increased with age. Patients above 60 years old wore the device 87.2% of the time, while those aged 45 to 59 were a close second at 86.7%. At the low end, patients 18 to 24 years old only wore their device 76.6% of the time.
Source Fool.com
